These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33014990)

  • 1. Structure-Guided Designing and Evaluation of Peptides Targeting Bacterial Transcription.
    Kaur G; Kapoor S; Kaundal S; Dutta D; Thakur KG
    Front Bioeng Biotechnol; 2020; 8():797. PubMed ID: 33014990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Increasing the Affinity of CarD for RNA Polymerase on Mycobacterium tuberculosis Growth, rRNA Transcription, and Virulence.
    Garner AL; Rammohan J; Huynh JP; Onder LM; Chen J; Bae B; Jensen D; Weiss LA; Manzano AR; Darst SA; Campbell EA; Nickels BE; Galburt EA; Stallings CL
    J Bacteriol; 2017 Feb; 199(4):. PubMed ID: 27920294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-throughput screening to discover inhibitors of the CarD·RNA polymerase protein-protein interaction in Mycobacterium tuberculosis.
    Stefan MA; Velazquez GM; Garcia GA
    Sci Rep; 2020 Dec; 10(1):21309. PubMed ID: 33277558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the Mtb CarD/RNAP β-lobes complex reveals the molecular basis of interaction and presents a distinct DNA-binding domain for Mtb CarD.
    Gulten G; Sacchettini JC
    Structure; 2013 Oct; 21(10):1859-69. PubMed ID: 24055315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription regulation by CarD in mycobacteria is guided by basal promoter kinetics.
    Zhu DX; Stallings CL
    J Biol Chem; 2023 Jun; 299(6):104724. PubMed ID: 37075846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting
    Stephanie F; Saragih M; Tambunan USF; Siahaan TJ
    Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription regulation by CarD in mycobacteria is guided by basal promoter kinetics.
    Zhu DX; Stallings CL
    bioRxiv; 2023 Mar; ():. PubMed ID: 36993566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CarD contributes to diverse gene expression outcomes throughout the genome of
    Zhu DX; Garner AL; Galburt EA; Stallings CL
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13573-13581. PubMed ID: 31217290
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Stephanie F; Tambunan USF; Siahaan TJ
    Life (Basel); 2022 Nov; 12(11):. PubMed ID: 36362929
    [No Abstract]   [Full Text] [Related]  

  • 11. CarD and RbpA modify the kinetics of initial transcription and slow promoter escape of the Mycobacterium tuberculosis RNA polymerase.
    Jensen D; Manzano AR; Rammohan J; Stallings CL; Galburt EA
    Nucleic Acids Res; 2019 Jul; 47(13):6685-6698. PubMed ID: 31127308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Mapping of the Distribution of CarD, RNAP σ
    Landick R; Krek A; Glickman MS; Socci ND; Stallings CL
    Genom Data; 2014 Dec; 2():110-113. PubMed ID: 25089258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CarD stabilizes mycobacterial open complexes via a two-tiered kinetic mechanism.
    Rammohan J; Ruiz Manzano A; Garner AL; Stallings CL; Galburt EA
    Nucleic Acids Res; 2015 Mar; 43(6):3272-85. PubMed ID: 25697505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of ω with the C-Terminal Region of the β' Subunit Is Essential for Assembly of RNA Polymerase in Mycobacterium tuberculosis.
    Mao C; Zhu Y; Lu P; Feng L; Chen S; Hu Y
    J Bacteriol; 2018 Jun; 200(12):. PubMed ID: 29632095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterial RNA polymerase forms unstable open promoter complexes that are stabilized by CarD.
    Davis E; Chen J; Leon K; Darst SA; Campbell EA
    Nucleic Acids Res; 2015 Jan; 43(1):433-45. PubMed ID: 25510492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting bacterial RNA polymerase σ70 for development of broad-spectrum antisense antibacterials.
    Bai H; Bo X; Wang S
    Recent Pat Antiinfect Drug Discov; 2012 Dec; 7(3):213-22. PubMed ID: 22742395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of Mycobacterium tuberculosis CarD, an essential RNA polymerase binding protein, reveals a quasidomain-swapped dimeric structural architecture.
    Kaur G; Dutta D; Thakur KG
    Proteins; 2014 May; 82(5):879-84. PubMed ID: 24115125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication from the predicted docked interaction of sigma H and exploration of its interaction with RNA polymerase in Mycobacterium tuberculosis.
    Gupta AM; Bhattacharya S; Bagchi A; Mandal S
    Bioinformation; 2015; 11(6):296-301. PubMed ID: 26229290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.